Cargando…
Hypometabolism as a therapeutic target in Alzheimer's disease
The pathology of Alzheimer's disease (AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain...
Autores principales: | Costantini, Lauren C, Barr, Linda J, Vogel, Janet L, Henderson, Samuel T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604900/ https://www.ncbi.nlm.nih.gov/pubmed/19090989 http://dx.doi.org/10.1186/1471-2202-9-S2-S16 |
Ejemplares similares
-
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
por: Raut, Snehal, et al.
Publicado: (2023) -
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
por: Henderson, Samuel T, et al.
Publicado: (2009) -
Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017) -
Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease
por: Scheltens, Nienke M.E., et al.
Publicado: (2018) -
Brain Glucose Hypometabolism and Iron Accumulation in Different Brain Regions in Alzheimer’s and Parkinson’s Diseases
por: Rao, Indira Y., et al.
Publicado: (2022)